Second malignancies in multiple myeloma; emerging patterns and future directions.

Best Practice & Research. Clinical Haematology
Kylee MaclachlanDickran Kazandjian

Abstract

The changing landscape of treatment options for multiple myeloma has led to a higher proportion of patients achieving deep, long-lasting responses to therapy. With the associated improvement in overall survival, the development of subsequent second malignancies has become of increased significance. The risk of second malignancy after multiple myeloma is affected by a combination of patient-, disease- and therapy-related risk factors. This review discusses recent data refining our knowledge of these contributing factors, including current treatment modalities which increase risk (i.e. high-dose melphalan with autologous stem cell transplant and lenalidomide maintenance therapy). We highlight emerging data towards individualized risk- and response-adapted treatment strategies and discuss key areas requiring future research.

References

Oct 4, 1979·The New England Journal of Medicine·D E BergsagelA B Miller
Nov 1, 1996·British Journal of Haematology·R GovindarajanG Tricot
Jan 5, 2006·Journal of the National Cancer Institute·Lois B TravisMark H Greene
Jan 6, 2006·International Journal of Cancer. Journal International Du Cancer·Ola LandgrenLynn R Goldin
Sep 29, 2007·Human Molecular Genetics·Patrick J HaydenMark Lawler
Jul 11, 2008·The New England Journal of Medicine·Henry T LynchStephan Thomé
Apr 13, 2012·Nature Reviews. Cancer·Gareth J MorganFaith E Davies
Apr 19, 2012·Haematologica·Sergio MatarrazUNKNOWN GEM Grupo Español de MM/Programa para el Estudio de la Terapéutica en Hemopatías Malignas Co-operative Study Groups
May 11, 2012·The New England Journal of Medicine·Antonio PalumboUNKNOWN MM-015 Investigators
May 11, 2012·The New England Journal of Medicine·Philip L McCarthyCharles Linker
May 11, 2012·The New England Journal of Medicine·Michel AttalUNKNOWN IFM Investigators
Oct 4, 2012·Journal of Hematology & Oncology·Kari HemminkiKristina Sundquist
Oct 11, 2012·International Journal of Cancer. Journal International Du Cancer·Theodora PsaltopoulouMeletios A Dimopoulos
Jun 5, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andy C RawstronRoger G Owen
Aug 16, 2013·Nature·Ludmil B AlexandrovMichael R Stratton
Aug 21, 2013·Nature Genetics·Daniel ChubbHartmut Goldschmidt
Aug 22, 2013·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Gabriella AndreottiMark P Purdue
Nov 20, 2013·Leukemia·G J MorganR S Houlston
Dec 7, 2013·Expert Review of Hematology·María-Victoria MateosJesús-F San Miguel
Jan 29, 2014·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Matteo RotaCarlo La Vecchia

❮ Previous
Next ❯

Related Concepts

Related Papers

Medizinische Monatsschrift für Pharmazeuten
Annemarie Musch
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Nikhil C Munshi, Kenneth C Anderson
© 2021 Meta ULC. All rights reserved